New Key Statistics Module, Z-Score and F-Score
NAS:ESPR Key Ratios
| Market Cap $ M | 375.01 |
| Enterprise Value $ M | 587.34 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.77 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 116.00 |
| EPS (TTM) $ | -2.12 |
| Beneish M-Score | -3 |
| 10-y EBITDA Growth Rate % | -0.40 |
| 5-y EBITDA Growth Rate % | 21.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.91 |
| EV-to-EBITDA | -3.92 |
| PEG | -- |
| Shares Outstanding M | 189.40 |
| Net Margin (%) | -179.87 |
| Operating Margin % | -133.72 |
| Pre-tax Margin (%) | -179.87 |
| Quick Ratio | 0.87 |
| Current Ratio | 1.29 |
| ROA % (ttm) | -90.08 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -581.89 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.76 |
ESPR Number of Guru Trades
ESPR Volume of Guru Trades
Gurus Latest Trades with NAS:ESPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ESPR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Esperion Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ESPR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers